Clinical outcomes and health care costs combining metformin with sitagliptin or sulphonylureas or thiazolidinediones in uncontrolled type 2 diabetes patients

OBJECTIVES: To compare clinical outcomes and health care costs across three cohorts of uncontrolled diabetic patients who initiated treatment with one of the following: sulphonylureas (SU), thiazolidinediones (TZD) or sitagliptin (SITA). MATERIALS AND METHODS: We performed a retrospective study base...

Descripción completa

Detalles Bibliográficos
Autores principales: Degli Esposti, Luca, Saragoni, Stefania, Buda, Stefano, Degli Esposti, Ezio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4211865/
https://www.ncbi.nlm.nih.gov/pubmed/25364266
http://dx.doi.org/10.2147/CEOR.S63666

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4211865/
https://www.ncbi.nlm.nih.gov/pubmed/25364266
http://dx.doi.org/10.2147/CEOR.S63666

Ejemplares similares